WallStreetZenWallStreetZen

NASDAQ: ICAD
Icad Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ICAD past revenue growth

How has ICAD's revenue growth performed historically?
Company
7.41%
Industry
10.46%
Market
16.68%
ICAD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ICAD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ICAD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ICAD earnings and revenue history

Current Revenue
$18.8M
Current Earnings
-$2.3M
Current Profit Margin
-12.1%

ICAD Return on Equity

Current Company
-7.1%
Current Industry
9.3%
Current Market
34.1%
ICAD's Return on Equity (-7.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ICAD announces earnings.

ICAD Return on Assets

Current Company
-5.5%
Current Industry
5.5%
ICAD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ICAD Return on Capital Employed

Current Company
-6.93%
Current Industry
8.9%
ICAD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ICAD vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ICAD$18.80M-$1.46M-$2.28M-7.16%N/A
ALUR$47.59M-$27.27M-$37.64M-15.85%N/A
ECOR$21.28M-$13.29M-$14.23M+68.84%N/A
RPID$24.71M-$49.96M-$50.46M+52.35%N/A
AXDX$12.23M-$24.47M-$37.91M+12.68%N/A
View Top Medical Device Stocks

Icad Earnings & Revenue FAQ

What were ICAD's earnings last quarter?

On Invalid Date, Icad (NASDAQ: ICAD) reported Q2 2024 earnings per share (EPS) of -$0.07, up 0% year over year. Total Icad earnings for the quarter were -$1.74 million. In the same quarter last year, Icad's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Icad stock.

What was ICAD's earnings growth in the past year?

As of Q3 2024, Icad's earnings has grown year over year. Icad's earnings in the past year totalled -$2.28 million.

What was ICAD's revenue last quarter?

On Invalid Date, Icad (NASDAQ: ICAD) reported Q2 2024 revenue of $5.03 million up 20.57% year over year. In the same quarter last year, Icad's revenue was $4.17 million.

What was ICAD's revenue growth in the past year?

As of Q3 2024, Icad's revenue has grown 7.41% year over year. This is 3.05 percentage points lower than the US Medical Devices industry revenue growth rate of 10.46%. Icad's revenue in the past year totalled $18.80 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.